Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,211.20
(
0.00%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
94.26
(
-2.81%
)
Bitcoin
75,741.06
(
-0.14%
)
News Focus
News Focus

Replies to post #431 on Fate Therapeutics Inc (FATE)

Replies to #431 on Fate Therapeutics Inc (FATE)
icon url

NY1972

10/24/24 1:59 PM

#432 RE: jondoeuk #431

How about the smell buds CXCR2? 825 has more than 99% bio investors.
icon url

NY1972

10/25/24 12:43 AM

#433 RE: jondoeuk #431

825 doesn't have 1XX. Are they expecting IL7-RF and CD38KO to get persistence?
icon url

NY1972

10/29/24 5:15 PM

#438 RE: jondoeuk #431

Is FT825 CAR NKT cells?

Natural Killer T (NKT) Cells: Some NKT cells express CD16a, which can allow them to mediate antibody-dependent cellular cytotoxicity (ADCC) in response to antibody-coated targets, a property more commonly associated with NK cells.